Healthpeak Properties, Inc.: Form 10-Q for the period ended Jun 30, 2019
Filed with the SEC on Aug 1, 2019 and accepted by EDGAR at Aug 1, 2019, 16:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-04-01 to 2019-06-30 | $177.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2019-01-01 to 2019-06-30 | $304.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-04-01 to 2019-06-30 | $214.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2019-01-01 to 2019-06-30 | $382.9m | us-gaap:CostOfGoodsAndServicesSold |
| Interest expense | 3 months2019-04-01 to 2019-06-30 | $56.9m | us-gaap:InterestExpense |
| Interest expense | 6 months2019-01-01 to 2019-06-30 | $106.3m | us-gaap:InterestExpense |
| Income tax | 3 months2019-04-01 to 2019-06-30 | −$1.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2019-01-01 to 2019-06-30 | −$5.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-04-01 to 2019-06-30 | −$13.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2019-01-01 to 2019-06-30 | $47.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-04-01 to 2019-06-30 | −$0.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2019-01-01 to 2019-06-30 | $0.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-04-01 to 2019-06-30 | −$0.03 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2019-01-01 to 2019-06-30 | $0.10 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-04-01 to 2019-06-30 | 478,739,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2019-01-01 to 2019-06-30 | 479,885,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2019-01-01 to 2019-06-30 | $380.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 6 months2019-01-01 to 2019-06-30 | $354.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2019-01-01 to 2019-06-30 | $4.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-06-30 | $130.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2019-06-30 | $13.71bn | us-gaap:Assets |
| Total liabilities | At period end2019-06-30 | $7.09bn | us-gaap:Liabilities |
| Long-term debt | At period end2019-06-30 | $6.23bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2019-06-30 | $6.05bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-19-009779. Last ingested by Listed: Nov 14, 2026, 21:09 ET. Listed shows no prices and gives no investment advice.